Sort
82,697 grants matching “vaccine development”
BIOMEDICAL RESEARCH INFRASTRUCTURE AT ALABAMA STATE UNI*
$776,703Alabama State University · P20 · FY2004 · MD
Inflammatory Triggers in B Cell Autoimmunity
$776,683Garnett H Kelsoe · Duke University · U19 · FY2009 · AI
Human Intestinal Mucosal Immune and Functional Response to S. typhi
$776,670Alessio Fasano · University Of Maryland Baltimore · U19 · FY2014 · AI
Development of lung T cell responses in infant respiratory immunity
$776,590Donna L Farber · Columbia University Health Sciences · U01 · FY2021 · AI
National Center of Rabbit Models for Translational Research
$776,504Yuqing E Chen · University Of Michigan At Ann Arbor · R24 · FY2025 · OD
Trans-complementing papillioma virus for AIDS vaccine
$776,478Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2016 · AI
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
$776,464Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2021 · AI
Pre-existing Adenovirus-Specific T Cells & their Effect on Chimp Adenovirus
$776,411Michael R Betts · Wistar Institute · U19 · FY2009 · AI
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
$776,353Venigalla B. Rao · Catholic University Of America · R01 · FY2017 · AI
An Adjuvanted Therapeutic DNA Vaccine for AIDS
$776,346Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · AI
Development of Broadly Neutralizing Nanobodies for Advancing AIDS Therapy
$776,329Jianliang Xu · Georgia State University · R01 · FY2025 · AI
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRY
$776,257Pavel A Pevzner · University Of California, San Diego · P41 · FY2009 · RR
Center for Computational Mass-Spectrometry
$776,257Pavel A Pevzner · University Of California, San Diego · P41 · FY2009 · RR
New retroviral restriction factor
$776,245Tatyana V. Golovkina · University Of Chicago · R56 · FY2021 · AI
Antigenic determinants of asthma-associated allergens for design of immunotherapy.
$776,237Anna Pomes · Indoor Biotechnologies · R01 · FY2017 · AI
Non-Human Primate Core
$776,234Ivona Pandrea · University Of Alabama At Birmingham · P01 · FY2010 · AI
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$776,214Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2020 · AI
An HIV Prevention Program for Mochudi, Botswana
$776,183Myron E Essex · Harvard School Of Public Health · R01 · FY2012 · AI
Inflammatory Triggers in B Cell Autoimmunity
$776,115Garnett H Kelsoe · Duke University · U19 · FY2010 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$776,096Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Immunoevasive Mucosal Vaccines Against HIV-1
$776,040Michael A Barry · Mayo Clinic Rochester · R01 · FY2015 · AI
Novel Prophylactic HIV Vaccines Based on rAAV Vectors
$776,021Research Inst Nationwide Children'S Hosp · P01 · FY2003 · AI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
$775,988John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Tethering lentiviral restriction to Fc-mediated antibody responses
$775,982David T Evans · University Of Wisconsin-Madison · R01 · FY2023 · AI
STRUCTURAL STUDIES ON ROTAVIRUS
$775,925Bidadi V Venkataram Prasad · Baylor College Of Medicine · R01 · FY2024 · AI